Lumida
/NATR
⌘K
Nature's Sunshine Products Inc

Nature's Sunshine Products Inc

NATR
$13.55USD↓-0.44%-0.06 today

MARKET CAP

238.4M

P/E (TTM)

12.3x

FWD P/E

—

DAY RANGE

$13 – $14

52W RANGE

$13
$28

AI Summary

Stalk
TrimMedium

Personal Care Products remains in a clear Stage 4 decline with a support failure signaling accelerating downside. Medium-term bias is bearish, and while the long-term trend is still up, the current momentum and lack of mean-reversion eligibility disallow fresh buys. With price deeply extended below EMAs and in oversold territory, we will Trim into any relief rallies rather than aggressively sell into exhaustion.

  • ↑Q2 net sales hit $117 M (+2% YoY) with strong 73.7% gross margin
  • ↑New CFO and North America EVP to drive efficiency and growth
  • ↓2026 guidance cut due to foreign exchange and China market pressures
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Nature's Sunshine Products, Inc. (NASDAQ:NATR) is a leading player in the health and wellness industry, specializing in dietary supplements and natural health products. The company has a strong presence in the North American and Asia-Pacific markets, catering to a growing customer base increasingly focused on preventive health solutions. Nature's Sunshine operates within the trend of wellness and nutraceuticals, leveraging innovations to enhance product efficacy and consumer trust.

Bull says

  • ↑Q2 net sales hit $117 M (+2% YoY) with strong 73.7% gross margin
  • ↑New CFO and North America EVP to drive efficiency and growth
  • ↑12-month price target of $30.50 implies 86% upside potential
  • ↑High earnings yield and robust profitability support future cash generation
  • ↑Positive momentum and news sentiment suggest continued stock traction
  • ↑Digital expansion and Asia-Pacific growth offer further revenue catalysts

Bear says

  • ↓2026 guidance cut due to foreign exchange and China market pressures
  • ↓Negative growth sentiment and downward revisions point to softening momentum
  • ↓High short interest signals investor skepticism and potential volatility
  • ↓Dividend yield challenges reflect margin pressure and limited shareholder returns
  • ↓Technical indicators show a sell signal amid lack of bullish trends
  • ↓Small market size heightens vulnerability to macro and competitive risks

Investment themes with NATR

Buybacks↓ -0.29%

Companies repurchasing their own shares

C · JCI · WFC

Earnings Call · Q2 2024 · Mgmt. Guidance

Updated 09-01-2025neutral

Transcript signals

Bull points

  • As we move forward, we expect the AOV headwind to subside and growth to re-accelerate.
  • 2% sales growth or 7% growth on a local currency basis, which was driven by a strong year-over-year increase in customers and orders, combined with increased adoption of our subscription offering, partially offset by a lower AOV.
  • We believe Korea is heading in the right direction and we expect continued measured improvement.

Bear points

  • Consolidated net sales in the second quarter were $110.6 million compared to $116.5 million in the year-ago quarter, a 5 percent decrease versus the prior year, or a 3 percent decrease, excluding the impact from foreign exchange rates.
  • Our China business accounted for most of the decline, with sales down 29%, or 26% on a local currency basis due to deteriorating economic conditions that continue to pressure consumer demand.
  • Gross margin in the second quarter decreased 125 basis points to 71.4%, compared to 72.6% a year ago. The decrease was primarily driven by the impact of inflation and unfavorable foreign exchange, as well as the timing of our price increases.
Read full transcript analysis ›